The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Dectin-1 Is A Major β-Glucan Receptor On Macrophages
Open accessAbstract
Zymosan is a β-glucan– and mannan-rich particle that is widely used as a cellular activator for examining the numerous responses effected by phagocytes. The macrophage mannose receptor (MR) and complement receptor 3 (CR3) have historically been considered the major macrophage lectins involved in the nonopsonic recognition of these yeast-derived particles. Using specific carbohydrate inhibitors, we show that a β-glucan receptor, but not the MR, is a predominant receptor involved in this process. Furthermore, nonopsonic zymosan binding was unaffected by genetic CD11b deficiency or a blocking monoclonal antibody (mAb) against CR3, demonstrating that CR3 was not the β-glucan receptor mediating this activity. To address the role of the recently described β-glucan receptor, Dectin-1, we generated a novel anti–Dectin-1 mAb, 2A11. Using this mAb, we show here that Dectin-1 was almost exclusively responsible for the β-glucan–dependent, nonopsonic recognition of zymosan by primary macro-phages. These findings define Dectin-1 as the leukocyte β-glucan receptor, first described over 50 years ago, and resolves the long-standing controversy regarding the identity of this important molecule. Furthermore, these results identify Dectin-1 as a new target for examining the immunomodulatory properties of β-glucans for therapeutic drug design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brown, G. D., & Gordon, S. (2001) · Nature · doi:10.1038/35092620 · Cited by 1,579
Self-citationThornton, B. P., Vĕtvicka, V, Pitman, M., Goldman, R. C., & Ross, G. D. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.3.1235 · Cited by 589
Identification of a Novel, Dendritic Cell-associated Molecule, Dectin-1, by Subtractive cDNA Cloning
Ariizumi, K., Shen, G.-L., Shikano, S., Xu, S., Ritter, R., Kumamoto, T., Edelbaum, D., Morita, A., Bergstresser, P. R., & Takashima, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909512199 · Cited by 468
Rat × rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG
GALFRÈ, G., MILSTEIN, C., & WRIGHT, B. (1979) · Nature · doi:10.1038/277131a0 · Cited by 402
Rosen, H., & Gordon, S. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.6.1685 · Cited by 360
Self-citationCharacterization of the Human β-Glucan Receptor and Its Alternatively Spliced Isoforms
Willment, J. A., Gordon, S., & Brown, G. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107715200 · Cited by 320
Self-citationTherapeutic intervention with complement and β-glucan in cancer
Ross, G. D., Větvička, V., Yan, J., Xia, Y., & Větvičková, J. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00013-2 · Cited by 283
Xia, Y., Vetvicka, V., Yan, J., Hanikýřová, M., Mayadas, T. N., & Ross, G. D. (1999) · PubMed · Cited by 265
Sterically Hindered Analogs of Thyroxine
Kharasch, N., & Saha, N. N. (1958) · Science · doi:10.1126/science.127.3301.756-a · Cited by 262
Pearson, A., Lux, A., & Krieger, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.4056 · Cited by 249
Cited by
Items 101–101 of 101
Cek1 regulates ß(1,3)-glucan exposure through calcineurin effectors in Candida albicans
Wagner, A. S., Lumsdaine, S. W., Mangrum, M. M., King, A. E., Hancock, T. J., Sparer, T. E., & Reynolds, T. B. (2022) · PLOS Genetics · doi:10.1371/journal.pgen.1010405 · Cited by 12
Metadata
- Authors
- Brown, G. D., Taylor, P. R., Reid, D. M., Willment, J. A., Williams, D. L., Martinez-Pomares, L., Wong, S. Y. C., & Gordon, S.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2002-07-29
- Volume
- 196
- Issue
- 3
- Pages
- 407-412
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2107531246
- Cited by
- 1,014
- References
- 27
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.